CCO Annual Update: Direct-Acting Antivirals in Treatment-Naive HCV Patients

August 16, 2011

CME/CE-CERTIFIED PROGRAM

HIV and Hepatitis C Annual Update 2011

Direct-Acting Antivirals in Treatment-Naive HCV Patients

Dear colleague,

I am pleased to share with you a CME/CE-certified educational module that I

authored for CCO's HIV

and Hepatitis C Annual Update. In this activity, I discuss the latest data on

and the approved indications for telaprevir and boceprevir in treatment-naive,

genotype 1 HCV–infected patients.

Topics covered include:

New Standard of Care for HCV Treatment

Direct-Acting Antivirals in HCV Treatment

Currently Approved Protease Inhibitors in HCV Treatment

Ribavirin: A Critical Component in HCV Treatment

Boceprevir in Treatment-Naive Patients With Genotype 1 HCV

Telaprevir in Treatment-Naive Patients With Genotype 1 HCV

Contraindications and Intolerance to PegIFN/RBV

I encourage you to review this module for strategies to prevent liver disease

progression in your HCV-infected patients.

To begin this module, click here.

Regards,

Mark S. Sulkowski, MD

Associate Professor of Medicine

Medical Director, Viral Hepatitis Center

Divisions of Infectious Diseases and Gastroenterology/Hepatology

s Hopkins University School of Medicine

Baltimore, land

The CCO HIV and Hepatitis Annual Update 2011 is located online at:

http://clinicaloptions.com/Hepatitis/Annual%20Updates/2011%20Annual%20Update.asp\

x

Physicians: Jointly sponsored by

the Annenberg Center for Health Sciences at Eisenhower and Clinical Care

Options, LLC.

Nurses: Annenberg Center for Health Sciences is accredited as a provider of

continuing nursing education by the American Nurses Credentialing Center's

Commission on Accreditation.

Pharmacists: The Annenberg Center for Health Sciences at

Eisenhower is accredited by the Accreditation Council for Pharmacy Education as

a provider of continuing pharmacy education.

Release date: August 2, 2011

Expiration date: August 1, 2012

Supported by educational grants from Abbott Laboratories, Gilead Sciences, Merck

& Co, Tibotec, and Vertex

Clinical Care Options Hepatitis

GET MORE FROM CCO

Visit the CCO Hepatitis Free Bookstore

Request your free copies of popular print programs from Clinical Care Options.

Available in the United States and

Canada only.

Click here to start.

Conference Coverage

Journal Options

Management Series

Treatment Updates

Interactive Cases

Live Meetings

RSS / Podcasts

My CME Tracker

Free Bookstore

Slide Downloads

White Drive, Suite 110, Reston, VA 20191-5433

To ensure you receive Clinical Care Options educational materials by email,

please add

info@... to your contacts or address book.

August 16, 2011